Comparison of Two Different Rehabilitation Approaches Applied After Anterior Cruciate Ligament Reconstruction
Launched by MARMARA UNIVERSITY · Feb 14, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different rehabilitation methods for people who have had surgery to repair a torn anterior cruciate ligament (ACL) in their knee. The goal is to see which method helps improve pain, movement, balance, quality of life, and fear of movement (kinesiophobia) after surgery. One group will do regular physical therapy along with exercises that require them to think or do two things at once (called dual-task exercises), while the other group will do the same exercises but also use a foam roller, which is a tool that helps relieve muscle tightness.
To participate, you need to be between 18 and 40 years old, have had ACL reconstruction surgery using a specific type of graft, and be at least one week but no more than one year post-surgery. However, you cannot have any serious heart conditions, additional knee injuries, or certain neurological issues that affect balance. If you join the trial, you can expect to follow a rehabilitation program that aims to help you recover and return to your normal activities as effectively as possible.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Undergoing anterior cruciate ligament (ACL) reconstruction. Use of hamstring tendon autograft. Age between 18 and 40 years. At least 1 week but no more than 1 year post-surgery.
- Exclusion Criteria:
- • Presence of cardiovascular diseases. Any additional lower extremity disability (e.g., revision ACL reconstruction, other knee surgeries).
- • Diagnosis of back or lumbar pain. Any neurological disorders that could affect balance (e.g., epilepsy). Presence of posterior cruciate ligament (PCL) tear in addition to ACL injury.
About Marmara University
Marmara University is a distinguished academic institution located in Istanbul, Turkey, renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust infrastructure and a multidisciplinary approach, the university actively engages in the development and evaluation of new therapeutic interventions, fostering collaboration among researchers, clinicians, and industry partners. Marmara University’s focus on ethical standards and patient safety underscores its dedication to contributing valuable insights to the medical community and improving health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Maltepe, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported